SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-005730
Filing Date
2023-04-11
Accepted
2023-04-11 16:23:06
Documents
112
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 20-F lvtx-20221231x20f.htm   iXBRL 20-F 3842044
2 EX-2.1 lvtx-20221231xex2d1.htm EX-2.1 197833
3 EX-4.4 lvtx-20221231xex4d4.htm EX-4.4 151483
4 EX-12.1 lvtx-20221231xex12d1.htm EX-12.1 25331
5 EX-12.2 lvtx-20221231xex12d2.htm EX-12.2 24872
6 EX-13.1 lvtx-20221231xex13d1.htm EX-13.1 9466
7 EX-13.2 lvtx-20221231xex13d2.htm EX-13.2 9440
8 EX-15.1 lvtx-20221231xex15d1.htm EX-15.1 3260
9 GRAPHIC lvtx-20221231x20f001.jpg GRAPHIC 7670
10 GRAPHIC lvtx-20221231x20f002.jpg GRAPHIC 82463
11 GRAPHIC lvtx-20221231x20f003.jpg GRAPHIC 12125
12 GRAPHIC lvtx-20221231x20f004.jpg GRAPHIC 71238
  Complete submission text file 0001558370-23-005730.txt   13738069

Data Files

Seq Description Document Type Size
13 EX-101.SCH lvtx-20221231.xsd EX-101.SCH 93960
14 EX-101.CAL lvtx-20221231_cal.xml EX-101.CAL 62968
15 EX-101.DEF lvtx-20221231_def.xml EX-101.DEF 259460
16 EX-101.LAB lvtx-20221231_lab.xml EX-101.LAB 588856
17 EX-101.PRE lvtx-20221231_pre.xml EX-101.PRE 479375
106 EXTRACTED XBRL INSTANCE DOCUMENT lvtx-20221231x20f_htm.xml XML 2637253
Mailing Address YALELAAN 62 UTRECHT P7 3584 CM
Business Address YALELAAN 62 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Filer) CIK: 0001840748 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-40241 | Film No.: 23813655
SIC: 2834 Pharmaceutical Preparations